Is Disc Medicine, Inc. (IRON) a Buy, Sell, or Hold?
NASDAQ : IRON
Disc Medicine, Inc.
$74.61 USD
$0.49 (0.66%)
- Volume
- 267.86K
- Average Volume
- 570.65K
- Market Capitalization
- $2.85B
- P/E Ratio
- -11.24
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $99.50
- Year Low
- $40.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.00
Company Overview
NASDAQ
John D. Quisel
Biotechnology
Healthcare
IRON
155
US
USD
Liquidity Metrics
0.05
24.00
24.00
2.86
0.00
Sales & Valuation
-$
0.00
4.17
-14.16
-5.23
Profitability
-$6.01
-$212.18M
0.00%
0.00%
-36.95%
-32.20%
P/E Metrics
-11.24
0.25
0.25
Analyst Price Target & Rating
$100.00
$125.00
$85.00
2/5
11 Analysts
-25.39%
Financial Health Scores
26.52
1/9
$716.31M
$750.21M
$61.78M
-$238.6M
Key Metrics (TTM)
$2.77B
0.00
-11.64
24.00
-36.95%
-36.92%
-8.47%
-7.11%
-24387 days
Company Executives
| Name | Title |
|---|---|
| Pamela Stephenson | Chief Commercial Officer |
| Lisa Amaya Price | Chief Human Resources Officer |
| Jonathan Yu | Chief Opearating Officer |
| Rahul Rajan Kaushik | Chief Technical Officer |
| Srikanth Venkatraman | Senior Vice President & Head of Chemistry |
| Jean Franchi | Chief Financial Officer |
| William Jacob Savage | Chief Medical Officer |
| Brian MacDonald | Founder & Chair of Scientific Advisory Board |
| Donald William Nicholson | Executive Chairman |
| John D. Quisel | Chief Executive Officer, President & Director |
| Rahul Khara | Chief Legal Officer & Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Disc Medicine, Inc. (NASDAQ:IRON) Stock
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis. ...
2026-07-27 15:58:00
NEW YORK, July 27, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-24 11:37:00
New York, New York--(Newsfile Corp. - July 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-22 20:28:00
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
2026-07-22 20:28:00
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
2026-07-21 20:39:00
New York, New York--(Newsfile Corp. - July 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-20 18:30:00
NEW YORK, July 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-15 15:04:00
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
2026-07-14 14:45:00
NEW YORK, July 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Frequently Asked Questions
-
What is the current Disc Medicine, Inc. (IRON) stock price?
-
Disc Medicine, Inc.(NASDAQ:IRON) stock price is $74.61 in the last trading session. During the trading session, IRON stock reached the peak price of $99.5 while $40 was the lowest point it dropped to. The percentage change in IRON stock occurred in the recent session was 0.66% while the dollar amount for the price change in IRON stock was $0.49.
-
IRON's industry and sector of operation?
-
The NASDAQ listed IRON is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IRON?
-
Pamela Stephenson | Chief Commercial Officer
Lisa Amaya Price | Chief Human Resources Officer
Jonathan Yu | Chief Opearating Officer
Rahul Rajan Kaushik | Chief Technical Officer
Srikanth Venkatraman | Senior Vice President & Head of Chemistry -
How many employees does IRON have?
-
Number of IRON employees currently stands at 155. IRON operates from 321 Arsenal Street, Watertown, MA 02472, US.
-
Link for IRON official website?
-
Official Website of IRON is: https://www.discmedicine.com
-
How do I contact IRON?
-
IRON could be contacted at phone #617 674 9274 and can also be accessed through its website. IRON operates from 321 Arsenal Street, Watertown, MA 02472, US.
-
How many shares of IRON are traded daily?
-
The average number of IRON shares traded daily for last 3 months was 570.65K.
-
What is the market cap of IRON currently?
-
The market value of IRON currently stands at $2.85B with its latest stock price at $74.61